发明名称 COMBINATION THERAPY FOR TREATING, PREVENTING OR MANAGING PROLIFERATIVE DISORDERS AND CANCERS
摘要 The present invention relates to methods and compositions designed for the treatment, management or prevention of cancer. The methods of the invention comprise the administration of an effective amount of one or more inhibitors of JNK in combination with the administration of an effective amount of one or more other agents useful for cancer therapy. The invention also provides pharmaceutical compositions comprising one or more inhibitors of JNK in combination with one or more other agents useful for cancer therapy. In particular, the invention is directed to methods of treatment and prevention of cancer by the administration of an effective amount of one or more inhibitors of JNK in combination with standard and experimental chemotherapies, hormonal therapies, bone marrow transplants, stem cell replacement therapies, biological therapies/immunotherapies and/or radiation therapies for treatment or prevention of cancer. Also included are methods of treatment of cancer by the administration of one or more inhibitors of JNK in combination with surgery, alone or in further combination with standard and experimental chemotherapies, hormonal therapies, bone marrow transplants, stem cell replacement therapies, biological therapies/immunotherapies and/or radiation therapies.
申请公布号 CA2478338(A1) 申请公布日期 2003.09.18
申请号 CA20032478338 申请日期 2003.03.07
申请人 SIGNAL PHARMACEUTICALS, INC. 发明人 STEIN, BERND M.;ENNIS, BRUCE W.;WESTWICK, JOHN K.
分类号 C07D231/54;A61K31/282;A61K31/337;A61K31/40;A61K31/415;A61K31/416;A61K31/4196;A61K31/42;A61K31/425;A61K31/454;A61K31/4745;A61K31/505;A61K31/513;A61K31/519;A61K31/675;A61K31/704;A61K33/24;A61K39/395;A61K45/06;A61P9/10;A61P35/00;A61P35/02;A61P35/04;A61P43/00;C07D403/04;(IPC1-7):A61K31/40 主分类号 C07D231/54
代理机构 代理人
主权项
地址